Abbvie Ltd
Supplier — contracts won
£3.3bnTotal value£3,344,201,200 across every award on file
6Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 4 | £3.3bn |
| Medicines Procurement and Supply Chain (MPSC) | 2 | £73.0m |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 28 Oct 2024 | NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | NHS England | Gilead Sciences Limited +12 | £626.5m |
| 25 Jul 2024 | NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 | NHS England | Bayer Plc +8 | £416.8m |
| 24 Jan 2025 | NHS National Framework Agreement - Inhalation Anaesthetics and VaporisersEngland | Medicines Procurement and Supply Chain (MPSC) | Abbvie Ltd +2 | £36.5m |
| 24 Jan 2025 | option or options to extend (at the discretion of the Authority) for a period or periods…England | Medicines Procurement and Supply Chain (MPSC) | Abbvie Ltd +2 | £36.5m |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.